Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Medtronic

Medtronic (NYSE: MDT) insider transactions

In the twelve months to 10 November 2026, executives and directors of Medtronic reported 18 open-market sales of 151,718 shares ($14.7m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Medtronic shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
2 November 2026Marinaro MichaelPresidentGrant or award+6,547—113,353Form 4
15 October 2026Lofton Kevin EDirectorOther−182—9,977Form 4
15 October 2026Martha GeoffreyChairman and CEOOpen-market sale, 10b5-1 plan−50,000$95.00277,866Form 4
15 October 2026Marinaro MichaelEVP, Pres MedSurg and AmericasOpen-market sale, 10b5-1 plan−10,420$96.00105,916Form 4
16 September 2026Kiil Harry SkipEVP & President CardiovascularOpen-market sale−1,483$93.6542,186Form 4
15 September 2026Blomquist Denise L.Chief Accounting OfficerGift−600—16,398Form 4
20 August 2026Marinaro MichaelEVP, Pres MedSurg and AmericasShares withheld for tax−1,084$92.30116,336Form 4
3 August 2026Martha GeoffreyChairman and CEOGrant or award+41,533—327,866Form 4
3 August 2026Kiil Harry SkipEVP & President CardiovascularGrant or award+9,230—43,669Form 4
3 August 2026Quinn MichelleEVP, GC and SecretaryGrant or award+6,346—26,721Form 4
3 August 2026Marinaro MichaelEVP, Pres MedSurg and AmericasGrant or award+10,960—71,273Form 4
3 August 2026Marinaro MichaelEVP, Pres MedSurg and AmericasGrant or award+46,147—117,420Form 4
3 August 2026Walter Matthew R.SVP, Chief HR OfficerGrant or award+5,769—39,928Form 4
3 August 2026Pieton ThierryEVP & Chief Financial OfficerGrant or award+11,537—49,645Form 4
3 August 2026Blomquist Denise L.Chief Accounting OfficerGrant or award+2,337—16,998Form 4
3 August 2026Thompson KweliEVP & President, NeuroscienceGrant or award+6,923—35,390Form 4
31 July 2026Martha GeoffreyChairman and CEOShares withheld for tax−15,810$85.39286,333Form 4
31 July 2026Kiil Harry SkipEVP & President CardiovascularShares withheld for tax−3,074$85.3934,439Form 4
31 July 2026Marinaro MichaelEVP, Pres MedSurg and AmericasShares withheld for tax−3,356$85.3960,313Form 4
31 July 2026Walter Matthew R.SVP, Chief HR OfficerShares withheld for tax−1,675$85.3934,159Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Medtronic page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.